Basic information Safety Supplier Related

Alvespimycin

Basic information Safety Supplier Related

Alvespimycin Basic information

Product Name:
Alvespimycin
Synonyms:
  • 17-DIMETHYLAMINOETHYLAMINO-17-DEMETHOXYG
  • 17-DMAGhydrochloride
  • 17-[2-(Dimethylamino)ethylamino]-17-desmethylgeldanamycin
  • 17-Demethoxy-17-[[2-(dimethylamino)ethyl]amino]geldanamycin
  • Alvespimycin
  • 17-DMAG (Alvespimycin)
  • 17-DMAG
  • Unii-001L2fe0m3
CAS:
467214-20-6
MF:
C32H48N4O8
MW:
616.75
Product Categories:
  • Isotope Labelled Compounds
  • Amines
  • Heterocycles
  • Inhibitors
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
467214-20-6.mol
More
Less

Alvespimycin Chemical Properties

Melting point:
>270°C (dec.)
Boiling point:
810.5±65.0 °C(Predicted)
Density 
1.20
storage temp. 
Desiccate at -20°C
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
pka
8.48±0.70(Predicted)
color 
Very Dark Purple
More
Less

Safety Information

HS Code 
29419090
More
Less

Alvespimycin Usage And Synthesis

Description

Geldanamycin is a potent inhibitor of Hsp90 that has poor water solubility. 17-DMAG is a water-soluble derivative of geldanamycin which potently inhibits Hsp90 (IC50 = 24 nM) and has excellent bioavailability and tissue distribution in animals. Like other Hsp90 inhibitors, 17-DMAG has diverse anti-tumor actions and has potential in treating certain types of cancer. This compound also suppresses inflammation by interfering with signaling through the NF-κB pathway. 17-DMAG also ameliorates high fat diet-induced renal failure in a mouse model of diabetes.

Chemical Properties

Solid

Uses

17-DMAG is an analogue of Gelamycin (G304500) and 17-(Allylamino)geldanamycin (A549650). 17-DMAG acts as a Hsp90 inhibitor and displays more potent antitumor activity than 17-AAG.

Uses

The labelled derivative of the analogue of Gelamycin (G304500) and 17-(Allylamino)geldanamycin (A549650). It acts as a Hsp90 inhibitor and displays more potent antitumor activity than 17-AAG.

Uses

17-DMAG is a synthetic Geldanamycin derivative and inhibitor of Hsp90.

Definition

ChEBI: A 19-membered macrocyle that is geldanamycin in which the methoxy group attached to the benzoquinone moiety has been replaced by a 2-(N,N-dimethylamino)ethylamino group.

Biological Activity

Water-soluble analog of 17-AAG (17-Demethoxy-17-(2-propenylamino)geldanamycin ) and geldanamycin (9,13-Dihydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-carbamate ). Binds the ATP binding site of Hsp90 and inhibits its chaperone activity. Displays more potent antitumor activity than 17-AAG (mean GI 50 values are 53 and 123 nM for 17-DMAG and 17-AAG respectively).

AlvespimycinSupplier

Shaanxi Cuikang Pharmaceutical Technology Co., Ltd Gold
Tel
18049165724 13186333400
Email
cuichengbio@163.com
Shaanxi Kebele Pharmaceutical R&D Co., Ltd Gold
Tel
13119135307
Email
3866620171@qq.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
China DongFan Chemical Co.,LTD
Tel
86-0571-85151182